Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
Kirsten Dahl, Søren Toubro, Sohan Dey, Ruben Vale, Anne Flint, Agnes Gasiorek, Arne Heydorn, Ania M. Jastreboff, Cassandra Key, Signe Beck Petersen, Andreas Vegge, Kasper Adelborg
Topics & Concepts
AmylinAgonistMedicinePharmacologyGlucagon-like peptide 1 receptorEndocrinologyInternal medicineDiabetes mellitusReceptorIsletDiabetes Treatment and ManagementRegulation of Appetite and ObesityChronic Kidney Disease and Diabetes